Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Matt Brams, MD
Cingulate
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida, United States
- Meridien Research
Maitland, Florida, United States
- Clinical Neuroscience Solutions, Inc.
Orlando, Florida, United States
- Atlanta Center for Medical Research
Atlanta, Georgia, United States
- Sisu Bhr, Llc
Springfield, Massachusetts, United States
- Neurobehavioral Medicine Group
Bloomfield Hills, Michigan, United States
- St Charles Psychiatric Associates & Midwest Research Group
Saint Charles, Missouri, United States
- Center for Psychiatry and Behavioral Medicine. Inc.
Las Vegas, Nevada, United States
- Hassman Research Institute
Berlin, New Jersey, United States
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Dayton Clinical Research
Dayton, Ohio, United States
- Sp Research Pllc
Oklahoma City, Oklahoma, United States
- Summit Research Network, Llc
Portland, Oregon, United States
- Coastal Pediatric Associates
Charleston, South Carolina, United States
- Coastal Carolina Research Center
North Charleston, South Carolina, United States
- Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee, United States
- Access Clinical Trials Inc.
Nashville, Tennessee, United States
- Biobehavioral Research of Austin
Austin, Texas, United States
- Gadolin Research
Beaumont, Texas, United States
- Houston Clinical Trials
Bellaire, Texas, United States
- Futuresearch Trials
Dallas, Texas, United States
- Red Oak Psychiatry Associates, Pa
Houston, Texas, United States
- Family Psychiatry of the Woodlands
Woodland, Texas, United States
- Clinical Research Partners Llc
Petersburg, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Aug 2023
- Primary completion
- 29 Feb 2024
- Completion
- 29 Feb 2024
- Last update posted
- 22 Jan 2026
- Registered enrollment
- 103
- Registry id
- NCT05286762
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.